Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,197 shares at $662.50 ($1.5M) on 2021-12-13, disclosed to the SEC on 2021-12-14.
Seasonal sale ($1.5M) by EVP Finance CFO — this insider has traded REGN in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $664.34 | 1,384 | $919K | 63.0% |
| 2 | $664.34 | 697 | $463K | 31.7% |
| 3 | $662.50 | 116 | $77K | 5.3% |
| Total | $664.24 avg | 2,197 | $1.5M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |